<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-MWI-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Malawi (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Malawi: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org ref="US-EIN-84-0399006" role="4" type="21">
   <narrative xml:lang="EN">The Aspen Institute</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Malawi</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="MW" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="MW" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Lilongwe</narrative>
   </name>
   <administrative code="MW" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-13.98333 33.78333</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1078469</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1472243</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">986458</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">71875</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="MWIPEF-TCA-ASPEN2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">148501</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-CARDNO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">125726</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">40000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-GFA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">15379</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">249759</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">30027</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">373847</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">95230</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-ASPEN2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">148501</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-CARDNO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">328780</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">156800</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-GFA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">9637</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">96901</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">26718</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">488138</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">216768</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-CARDNO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">324001</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">18000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">431098</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">213359</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MWIPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">71875</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001037">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">75943</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001203">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-50053</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001333">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-119091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006903">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-119091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006909">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-119091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006908">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-262345</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006912">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-262345</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006904">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006913">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006914">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006902">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">119091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">119091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006905">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">262345</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006915">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">262345</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006906">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006907">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006911">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006985">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000211">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">51937</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000210">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">93201</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700003906">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-01"></transaction-date>
   <value currency="USD" value-date="2020-10-01">-145138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700003906">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-01"></transaction-date>
   <value currency="USD" value-date="2020-10-01">145138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">-145138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">145138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-145138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">145138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001063">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">74405</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001230">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-26719</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001358">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">6602</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000235">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">71438</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001282">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">66216</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001700">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-07"></transaction-date>
   <value currency="USD" value-date="2020-05-07">64150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-15"></transaction-date>
   <value currency="USD" value-date="2020-09-15">67002</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-71438</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">71438</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15856</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-44119</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15856</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">44119</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005575">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">59975</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000168">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">-59975</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000660">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-16"></transaction-date>
   <value currency="USD" value-date="2021-02-16">59660</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000932">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">40000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">156800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001064">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-20861</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">11224</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003317">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-13"></transaction-date>
   <value currency="USD" value-date="2020-08-13">6227</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">216303</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-107141</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001273">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-74070</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001258">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">107141</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">107141</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001293">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">385</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003146">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-19"></transaction-date>
   <value currency="USD" value-date="2020-08-19">96901</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-15"></transaction-date>
   <value currency="USD" value-date="2021-04-15">32125</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">220001</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">71875</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000259">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-31"></transaction-date>
   <value currency="USD" value-date="2022-01-31">-71875</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">26566</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-1791</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">2807</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">6625</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">300</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000933">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">373846</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">362750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">125388</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">21022</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">410076</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000934">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">95230</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">95189</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">121579</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">213359</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-malawi-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Malawi 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-malawi-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Malawi 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-malawi-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Malawi 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-malawi-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Malawi 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-malawi-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Malawi 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-malawi-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Malawi 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-malawi-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Malawi 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-malawi-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Malawi 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-MWI" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(i) Nation-wide MR Follow-up campaign launched and accomplished (iii) Immunisation coverage and equity analysis updated and the most unreached and underserved population/community identified.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to MOH and Districts to improve overall coordination and management of national immunisation programme focusing on equity-focused immunisation programmes : 
i) Strategic planning, programme design and development;
ii) Assessing and identifying gaps in vaccine forecasting and supply planning, and implementing strategies and tools to improve forecasting practices including data quality, methods and processes
iii) Cold chain systems strengthening;
iv) Immunization equity assessment and equity-focused programming for the marginalised and underserved population (Equity-focused programming); vi) Support with planning, implementation and monitoring of the MR SIA follow up campaign, IPV catch up campaign and TCV introduction">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">(i) The nationwide Follow Up campaign has been postponed to Q1 next year, to integrate with TCV campaign for purposes of synergy, cost-efficiency and to allow for prioritization of COVID-19 vaccination this year. This Campaign will be used as a platform to include other RI critical activities Including social mobilization and demand creation, vaccine safety and data for decision making. Vaccine distribution and logistics at all levels will also be strengthened through integration during the campaign. All Supervisions before, during and after the campaign will include RI components. RI Data Collection and reporting tools will be revised and printed to incorporate Typhoid vaccine and the tools will be printed and distributed to all Health facilities for RI data collection and reporting. Those Children that are due for the Routine Immunizations ie MR, RTSS will be identified and immunized during the campaigns(ii) A national consultant has been recruited and is currently working on the development of the Zero Dose strategy for the country. The assignment will also review and update the Immunization coverage and equity analysis and identify the most unreached and underserved population/community. The report is is expected to be finalized in December, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i) MOH Annual Implementation Plan (AIP) for EPI programme 2021-22 finalised;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to MOH and Districts to improve overall coordination and management of national immunisation programme focusing on equity-focused immunisation programmes : 
i) Strategic planning, programme design and development;
ii) Assessing and identifying gaps in vaccine forecasting and supply planning, and implementing strategies and tools to improve forecasting practices including data quality, methods and processes
iii) Cold chain systems strengthening;
iv) Immunization equity assessment and equity-focused programming for the marginalised and underserved population (Equity-focused programming); vi) Support with planning, implementation and monitoring of the MR SIA follow up campaign, IPV catch up campaign and TCV introduction">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">EPI Annual Implementation plan was completed in first quarter, 2021 and UNICEF provided TA support to successfully draft the plan.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training completed and assessed. Final assessment resullts shared with MoH and key partners.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct a mapping exercise of Malawi AEFI surveillance system. Develop and implement a training package for AEFI surveillance targeting frontline health workers that aligns with system components.">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">A coordinator was hired and activities have been conducted in spite of COVID-19. A needs assessment of Malawi?s adverse events following immunization (AEFI) surveillance system was conducted prior to development and implementation of a training package for AEFI surveillance targeting frontline health workers that aligns with system components. Six districts were involved in the needs training assessment. An assessment has been added to assess the effect of training on improving AEFI reporting 6 months following training of 313 frontline healthcare workers from 6 districts. This will be completed by December 31, 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct a mapping exercise of Malawi AEFI surveillance system. Develop and implement a training package for AEFI surveillance targeting frontline health workers that aligns with system components.">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">A coordinator was hired and activities have been conducted in spite of COVID-19. A needs assessment of Malawi?s adverse events following immunization (AEFI) surveillance system was conducted prior to development and implementation of a training package for AEFI surveillance targeting frontline health workers that aligns with system components. Six districts were involved in the needs training assessment. An assessment has been added to assess the effect of training on improving AEFI reporting 6 months following training of 313 frontline healthcare workers from 6 districts. This will be completed by December 31, 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct a mapping exercise of Malawi AEFI surveillance system. Develop and implement a training package for AEFI surveillance targeting frontline health workers that aligns with system components.">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The evaluation of the training project will be completed using CDC funds but a final report on the assessment results will be shared with MoH and Gavi before December 31. CDC is also working on a manuscript and will share with Gavi in the future.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training materials piloted and finalized. Training areas and particpants identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct a mapping exercise of Malawi AEFI surveillance system. Develop and implement a training package for AEFI surveillance targeting frontline health workers that aligns with system components.">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">A needs assessment of Malawi?s adverse events following immunization (AEFI) surveillance system was conducted prior to development and implementation of a training package for AEFI surveillance. This training was targeting frontline health workers and aligns with system components. Six districts were involved in the needs training assessment. An assessment has been added to assess the effect of training on improving AEFI reporting 6 months following training of 313 frontline healthcare workers from the six districts. This will be completed by December 31, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final Comprehensive EPI review technical report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Activity not yet implemented. Was rescheduled to November 2021 but implementation may not be possible due to competing priorities mainly due to the focus on delivery of the large number of COVID-19 vaccine doses needing to be fully utilised before expiry date of December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Comprehensive review concept note and adapted tools</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Draft concept note is available. Scheduling the activity has been a challenge due to competing priorities</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The concept note and tools are under development. Activity has been scheduled for October 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final Comprehensive EPI review &amp; IPV PIE technical report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review combined with IPV PIE May 2020">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Concept note and tools under development</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final MR supplementary immunization application submitted to GAVI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to Develop Measles Rubella supplementary Immunisation Application document to Gavi">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Malawi&apos;s application was accepted by Gavi. The MR SIA is tentatively scheduled for October 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to Develop Measles Rubella supplementary Immunisation Application document to Gavi">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Malawi&apos;s application was accepted by Gavi. The MR SIA is tentatively scheduled for October 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final Comprehensive EPI review and IPV PIE technical report submitted to MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review combined with IPV PIE May 2020">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Scheduling of this activity has been a challenge due to competing priorities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review combined with IPV PIE May 2020">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Scheduling of this activity is being affected by the shift in focus to COVID-19 response. The activity is being scheduled for this year</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct EPI comprehensive review combined with IPV PIE May 2020">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Scheduling of this activity is being affected by the shift in focus to COVID-19 response. The activity is being scheduled for this year</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evidence-based National ACSM strategic plan developped.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to review and revise National EPI Advocacy, Communication and Social Mobilisation (ACSM) strategic plan.">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Currently engaging an implementing partner to provide support for implementation of this activity which will also leverage on work under an existing integrated malaria (and MNCAH) project. This work is expected to be completed by October, 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly updates on communication and social mobilization activities prepared and presented at EPI Sub TWG meeting</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for skill transfer to the MOH Health Education Services unit to strengthen and coordinate Communication and Social Mobilization for immunization">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly updates on communication and social mobilization activities prepared and presented at Demand Sub-committee. Consolidated by UNICEF and HES and presented at EPI Sub-TWG and NTF meetings</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for skill transfer to the MOH Health Education Services unit to strengthen and coordinate Communication and Social Mobilization for immunization">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly updates on communication and social mobilization activities prepared and presented at Demand Sub-committee. Consolidated by UNICEF and HES and presented at EPI Sub-TWG and NTF meetings</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly Update on Messages diseminated presented at EPI sub TWG meeting</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Disseminate messages through community radios to increase demand for vaccines with emphasis on 2YL: Messages disseminated through electronic media">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Updates provided quarterly ( and as planned e.g. monthly/weekly) in Demand Creation sub-committee&apos;s, which are fed into consolidated NTF/TWG presentations by Health Education Services (HES)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Disseminate messages through community radios to increase demand for vaccines with emphasis on 2YL: Messages disseminated through electronic media">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Updates provided quarterly ( and as planned e.g. monthly/weekly) in Demand Creation sub-committee&apos;s, which are fed into consolidated NTF/TWG presentations by Health Education Services (HES)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">RTM system implemented in 30% of vaccine store</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH -Immunization Suppy Chain Unit, District health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM):
i) Technical assistance to implement the CCEOP-ODP and PSR-iSCM activities with procurement, distribution, installation, commissioning of CCEs and monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT);
ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems;
iii) Technical assistance to develop semi-annual Cold Chain Equipment (CCE) inventory;
iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies.
v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage.
vi) Contribute to the overall supply chain reform agenda of the health sector guided by the the iSCM HR/Data assessment recommendations. (vii) Support for implementation of Remote Temperature Monitoring (RTM) system in all 864 cold chain points across the country vii) Support planning and implementation of the MR Follow up SIA and TCV vaccine introduction vii) Support plannning ands implementation of the MR follow up SIA and TCV vaccine introduction">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">870 units of RTM devices have been procured, training of EPI Coordinators and Cold Chain Technicians has been planned for 26-29 November, 2021. The training wil include the installation of the devices hence it is expected that by mid-December, 2021, 50% of the RTM devices will be installed and the remaining 50% in January, 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TORs for EVMA TA assignment developed and candidate recruited by end of Q1 of 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support country team to conduct Effective Vaccine Management Assessment 2.0 with development of imrpovement plan and dynamic dashboard for easy of visualization and custome query features for data accessibility">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">A consultant was recruited by the UNICEF Regional Office to support countries including Malawi to conduct the EVMA. TORs were developed and a consultant is already on board. The consultant has supported Malawi to develop country profiles and train managers in readiness for the EVMA assignment planned to start in July, 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVMA assessemnet conducted, recommendations and improvement plans developed by end of Q3 of 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support country team to conduct Effective Vaccine Management Assessment 2.0 with development of imrpovement plan and dynamic dashboard for easy of visualization and custome query features for data accessibility">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">EVMA assessment has been conducted in September, 2021 with support from the UNICEF Regional Office. The report with draft recommendations has been prepared and is expected to be shared at the end of the month. Development of comprehensive improvement plan (cIP) has been scheduled from 29 Nov - 1st December, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ii) Monitoring plan for CCEOP implementation developed.

iv) One NLWG meetings and 1 PMT meetings held.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH -Immunization Suppy Chain Unit, District health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM):
i) Technical assistance to implement the CCEOP-ODP and PSR-iSCM activities with procurement, distribution, installation, commissioning of CCEs and monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT);
ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems;
iii) Technical assistance to develop semi-annual Cold Chain Equipment (CCE) inventory;
iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies.
v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage.
vi) Contribute to the overall supply chain reform agenda of the health sector guided by the the iSCM HR/Data assessment recommendations. (vii) Support for implementation of Remote Temperature Monitoring (RTM) system in all 864 cold chain points across the country vii) Support planning and implementation of the MR Follow up SIA and TCV vaccine introduction vii) Support plannning ands implementation of the MR follow up SIA and TCV vaccine introduction">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF provided support to develop the CCEOP monitoring plan as a key member in the CCEOP Program Management Team. During Q1 and Q2 of 2021, UNICEF participated in one National Logistics Technical Working Group meeting and two CCEOP Program Management Team meetings which provided relevant inputs in the development of Operational Deployment Plans for CCEOP 4 and 5 currently underway. UNICEF is also supporting the MOH to prepare for the Post Installation Inspection in the last week of July, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to development of MR SIA technical guidelines and training materials</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.	Development of MR SIA training materials and guidelines and technical support to trainings">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Anticipated funding for this SIA (from Gavi) has not yet been provided to the country, and Gavi has recommended that this be integrated with Typhoid vaccine introduction to be pushed forward to September/October 2022. JSI has continuously been part of discussions through technical working groups to prepare for the upcoming integrated MR/Typhoid SIA. However, given the postponement, guidance is requested from Gavi on how to proceed with this TA, given that it will not be a focus for the EPI and partners until probably Q2 of 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In collaboration with EPI and partners, develop key messages and materials for public communications and advocacy, to generate confidence, acceptance and demand for MR SIA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.	Technical support to the development of key messages and communication materials for MR SIA">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">As per the previous milestones, funding has not yet been provided to the country for the SIA, and Gavi has recommended that this be integrated with Typhoid vaccines to be pushed forward to September/October 2022. JSI has continuously been part of discussions through technical working groups to prepare for the upcoming integrated MR/Typhoid SIA. This support will be needed in Q2-Q3 2022, so JSI requests consultation with Gavi on how to proceed, given that this will be after the end date of the current contract.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft MVMH tool guidelines developed (adapted from previous versions)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Technical support to national roll out the My Village My Home (MVMH) approach">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Delayed due to competing priorities within EPI. JSI has started to revise the current guideline and tools for review and discussions during the workshop. The workshop for revising the draft will take place in December, 2021. JSI has been discussing with EPI about the importance of this activity in strengthening routine immunization. The program has been overwhelmed with COVID - 19 vaccination and the advice being provided to the program is not to neglect routine immunization activities because of COVID - 19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training sessions for district coordinators on the MVMH tool guideline and MVMH tool</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Technical support to national roll out the My Village My Home (MVMH) approach">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Delayed due to competing priorities within EPI. This is likely to take place in December 2021. JSI has been discussing with EPI about the importance of this activity in strengthening routine immunization. The program has been overwhelmed with COVID - 19 vaccinations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to EPI to develop MVMH training materials for nationwide use</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Technical support to national roll out the My Village My Home (MVMH) approach">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Delayed due to competing priorities within EPI. This is likely to take place in December, 2021. JSI has been discussing with EPI about the importance of this activity in strengthening routine immunization. The program has been overwhelmed with COVID - 19 vaccination and the advice being provided to the program is not to neglect routine immunization activities because of COVID - 19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supportive supervision visits conducted in 6 districts as part of MR SIA (districts determined in coordination with EPI and partners)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.	Technical support to monitor implementation of MR SIA and documentation of lessons learned">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Funding is not yet provided to the country and Gavi has recommended that this be integrated with the Typhoid campaign which is estimated to take place in September/ October 2022. Therefore, this support will not be possible before the current contract end date and will be discussed with Gavi.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical review of district level MR SIA microplans conducted in 10 districts and aggregated into national MR SIA microplan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	Technical support provided to MR SIA microplanninng">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Funding is not yet provided to the country and Gavi has recommended that this be integrated with the Typhoid campaign which is estimated to take place in September/ October 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In collaboration with EPI and partners, support data analysis of EPI performance from 2017 to 2021 in support of setting new targets, objectives and activities for the 2022-2027 cMYP (districts to be determined with EPI and partners)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7.	Technical support provided to the EPI to plan, monitor and evaluate the EPI program (i.e., support cMYP development and co-facilitation of MITAG meetings)">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">JSI continues to provide technical support to EPI through the TWG, to monitor, evaluate, and plan. The comprehensive review is expected to take place in January 2022, since the current cMYP is ending in 2021. JSI is working with other partners to provide support with the data analysis and coordination of preparations for the assessment and comprehensive review.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supportive supervision visits carried out in select districts to monitor HPV routinization (districts identified with the EPI and depending on need)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6.	Technical support to sustainability of routinization of HPV vaccination program">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Supervisory visits were conducted to 7 districts from September 24-30, 2021. The districts visited were Salima, Nkhotakota, Blantyre, Neno, Thyolo, Mulanje, and Zomba. Key findings included: availability of adequate vials of HPV vaccine; the vaccine is in good condition with a long shelf life (expiring in 2023); some districts still providing HPV vaccine despite high work load from COVID - 19 vaccinations. 
The concentration on COVID-19 vaccinations is affecting the HPV vaccine delivery; with the last vaccination sessions having taken place in July at both static and outreach locations. Misconceptions in the community continue about the use of COVID-19 vaccines instead of HPV vaccines during these sessions, with messaging suggested to the districts to address these. 
Other weaknesses include: low coverage of both doses of HPV vaccine at national level: 14% and 11% for HPV 1 and HPV 2 respectively as of August 2021; some facilities are not reporting doses given; more focused efforts needed by EPI to include cancer screening partners in the HPV vaccine in their messaging; no administration of HPV vaccines in most facilities, despite recommendations made in supervision visits; inadequate knowledge of district and facility staff on HPV routinization strategy; and lack of microplans in most facilities. 
However, health facilities started HPV vaccinations in October through static, outreach, and school sessions. There is a need to continue lobbying other partners to integrate HPV vaccine messages and encouraging districts to continue planning for HPV vaccination despite COVID-19 vaccinations. Community sensitization on the importance of HPV vaccination needs to be strengthened. JSI will continue with supervisory activities and airing of HPV vaccine messages in both national and community radios with funding from Merck.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Co-facilitation of MR SIA national training of trainers (TOT)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.	Development of MR SIA training materials and guidelines and technical support to trainings">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">TOT delayed due to delay in dates and funding not yet available from Gavi for the EPI. Gavi has recommended that this be integrated with the Typhoid campaign which is estimated to take place in September/ October 2022. (See also previous milestone.)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of District EPI Coordinators and HMIS Officers have capacity to use the WHO immunization app and data quality tool on DHIS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the CMED trainings of District EPI Coordinators and HMIS Officers on use of the WHO immunization app and data quality tool on DHIS">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Activity implementation affected by COVID-19 situation. WCO is engaging MoH on the scheduling of this activity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised EPI data collection tools with harmonised indicators available and ready for use</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support harmonisation of routine immunisation data collection tools ( health profile, Under two register, Tally book and all relevant immunisation data tools)">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Data quality review was conducted in September 2019. The next step was to conduct a data improvement plan workshop but that has still not taken place because of the COVID-19 situation</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support harmonisation of routine immunisation data collection tools ( health profile, Under two register, Tally book and all relevant immunisation data tools)">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Data quality review was conducted in September 2019. The next step was to conduct a data improvement plan workshop but that has still not taken place because of the COVID-19 situation</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support harmonisation of routine immunisation data collection tools ( health profile, Under two register, Tally book and all relevant immunisation data tools)">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Scheduling of this activity has been a challenge due to competing priorities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">90% of activities in harminisation of data collection tools have been implemented on time as planned</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support harmonisation of routine immunisation data collection tools ( health profile, Under two register, Tally book and all relevant immunisation data tools)">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Implementation has been affected by COVID-19 situation. WHO is engaging MoH on the scheduling of this activity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% District EPI Coordinators and HMIS Officers have capacity to use the WHO immunization app and data quality tool on DHIS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the CMED trainings of District EPI Coordinators and HMIS Officers on use of the WHO immunization app and data quality tool on DHIS">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been carried forward from 2019. It is still to be scheduled. Implementation in 2020/21 was affected my the COVID situation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the CMED trainings of District EPI Coordinators and HMIS Officers on use of the WHO immunization app and data quality tool on DHIS">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been carried forward from 2019. It is still to be scheduled. Implementation in 2020/21 was affected my the COVID situation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the CMED trainings of District EPI Coordinators and HMIS Officers on use of the WHO immunization app and data quality tool on DHIS">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was not scheduled despite many attempts. Competing priorities mainly related to the COVID-19 response were a major contributing factor</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">M &amp; E report for MOV/2YL activities submitted to MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for implementation of MOV 2YL, orientation of DHO EPI team on MOV/2YL strategies and Intergrated Supportive Supervision checklist, provide technical support for supportive supervision, M&amp; E of implementation of interventions in one district with low MR2 coverage">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Implementation plan has been revised and finalised. Training of DHMTs from implementing districts done. Some delays are being experienced to start orientation of vaccinators mainly due to a major shift in focus to COVID-19 response activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for implementation of MOV 2YL, orientation of DHO EPI team on MOV/2YL strategies and Intergrated Supportive Supervision checklist, provide technical support for supportive supervision, M&amp; E of implementation of interventions in one district with low MR2 coverage">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Implementation plan has been revised and finalised. Training of DHMTs from implementing districts done. Some delays are being experienced to start orientation of vaccinators mainly due to a major shift in focus to COVID-19 response activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for implementation of MOV 2YL, orientation of DHO EPI team on MOV/2YL strategies and Intergrated Supportive Supervision checklist, provide technical support for supportive supervision, M&amp; E of implementation of interventions in one district with low MR2 coverage">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Implementation plan, training tools and job aids are in place and DHMTs have been oriented. However implementation has not yet commenced due to competing priorities. Efforts to recruit a dedicated person for this work are underway.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of facilities with capacity to identify and vaccinate those who missed immunisations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for implementation of MOV 2YL, orientation of DHO EPI team on MOV/2YL strategies and Intergrated Supportive Supervision checklist, provide technical support for supportive supervision, M&amp; E of implementation of interventions in one district with low MR2 coverage">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Implementation plan is finalised</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to communications/social mobilization and community engagement activities, including coordination with cancer prevention organizations and CSOs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.4: Support communications/social mobilization and community engagement activities">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Due to the postponement of the HPV routinization until February 2021?and the need to mobilize funds for adaptation?ACSM activities were delayed until January 2021. JSI participated in a UNICEF-hosted workshop in January 2021 to review and revise communication materials to align with the HPV routinization strategy in collaboration with partners. Materials were updated to include messaging for girls to come to health facilities for HPV vaccination starting in February 2021 (and indicated that periodic vaccinations in schools may take place in the future) Thereafter, JSI reviewed the materials for finalization. Materials including a leaflet, flier, posters and a jingle, which was aired from February to March with support from Girl Effect. JSI, with funding from Merck, will support the revision of the jingle to fit the current routinization status, produce and continue airing on both national and community radios, planned for the months of August and September, 2021. The IEC materials are not yet printed due to lack of funding. 
JSI also advised districts to engage community health structures to share key messages about the HPV routinization?as described in the letter and guidance note?to districts and reiterated this important action during the virtual briefing in February 2021 and COVID-19 vaccination trainings in March 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to monitoring and evaluation of routine HPV vaccination, including documenting lessons learned to prepare for subsequent HPV doses</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.5: Support monitoring and evaluation activities">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">From March-May 2021, JSI conducted field visits with district coordinators in 20 districts: Salima, Dedza, Ntcheu, Nsanje, Thyolo, Balaka, Mchinji, Chitipa, Karonga, Rumphi, Mzimba North, Mzimba S, Nkhatabay, Mangochi, Kasungu,Mwanza, Blantyre, Mchinji, Machinga and Nkhotakota. The purpose of these visits was to monitor the HPV routinization progress, and as of May 2021, 20 out of 29 districts have begun vaccinating girls (both first and second dose). Visits revealed that all district coordinators were aware of HPV routinization; 80% of districts knew their targets for dose 1 and 2; 80% of districts had informed their health facilities of routinization; 100% of districts had HPV mapping and vaccination registers; and that most districts have engaged their education counterparts. However, several challenges were noted, including that some districts are running out of the revised performance report books that contain HPV vaccine; there are outstanding allowances from the previous HPV vaccination campaign has led to demotivation to begin routinization; 2021 microplanning is ongoing in some districts; health facilities do not have HPV vaccine monitoring charts and only 10% have ID cards; teachers? sit-in contributed to delay of HPV routinization in some districts; and some facilities have not started community mobilization activities. As a result, as of April 2021, uptake was low: the coverage was 5% for HPV 1 and 7% for HPV 2 and some HPV vaccine stock is at risk of expiring in mid-June 2021. Visit results were discussed in an HPV-specific TWG meeting, co-facilitated by the EPI and JSI in May 2021, and participants identified recommendations to strengthen the routinization of HPV (see attached presentation).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.5: Support monitoring and evaluation activities">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">From March-May 2021, JSI conducted field visits with district coordinators in 20 districts: Salima, Dedza, Ntcheu, Nsanje, Thyolo, Balaka, Mchinji, Chitipa, Karonga, Rumphi, Mzimba North, Mzimba S, Nkhatabay, Mangochi, Kasungu,Mwanza, Blantyre, Mchinji, Machinga and Nkhotakota. The purpose of these visits was to monitor the HPV routinization progress, and as of May 2021, 20 out of 29 districts have begun vaccinating girls (both first and second dose). Visits revealed that all district coordinators were aware of HPV routinization; 80% of districts knew their targets for dose 1 and 2; 80% of districts had informed their health facilities of routinization; 100% of districts had HPV mapping and vaccination registers; and that most districts have engaged their education counterparts. However, several challenges were noted, including that some districts are running out of the revised performance report books that contain HPV vaccine; there are outstanding allowances from the previous HPV vaccination campaign has led to demotivation to begin routinization; 2021 microplanning is ongoing in some districts; health facilities do not have HPV vaccine monitoring charts and only 10% have ID cards; teachers? sit-in contributed to delay of HPV routinization in some districts; and some facilities have not started community mobilization activities. As a result, as of April 2021, uptake was low: the coverage was 5% for HPV 1 and 7% for HPV 2 and some HPV vaccine stock is at risk of expiring in mid-June 2021. Visit results were discussed in an HPV-specific TWG meeting, co-facilitated by the EPI and JSI in May 2021, and participants identified recommendations to strengthen the routinization of HPV (see attached presentation).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to facilitate a stakeholder review exercise to identify key activities that need long-term support for sustainability of the HPV vaccination program and for inclusion in the upcoming country multi-year planning (cMYP)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.6: Support sustainability of HPV vaccination program">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">In May 2021, JSI co-facilitated a TWG meeting with key stakeholders to discuss the HPV routinization progress, including key challenges and successes, and with a focus on a way forward for the sustainability of the program, which includes strengthening collaboration and and coordination with non-EPI partners with a vested interest in HPV. Participants also received updates on other cervical cancer elimination strategies, including screening and HPV testing and treatment. Participants included the EPI TWG members, the MOH school health coordinator, integrated cervical cancer control partners, and the reproductive health unit adolescent health coordinator. In light of the cMYP update taking place this year, the participants discussed key HPV activities that require targeted attention in the next cMYP period (2022-2027). The activities include: community engagement on HPV vaccination; media engagement on HPV vaccination; integration of HPV vaccines into PIRIs; integration of HPV into supportive supervision visits; inclusion of HPV in tracking tools; and conducting a MAC. A key focus of HPV vaccination moving forward also includes active integration into related programs, such as reproductive and adolescent health programs and the cervical cancer program. Key next steps include participating in the cervical cancer elimination strategy revision to include HPV vaccination, incorporating key HPV vaccination activities into the cMYP revision, and collaborating and coordinating with relevant stakeholders to incorporate HPV programming into existing activities, platforms, programs, and communication networks.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to communications/social mobilization and community engagement activities, including coordination with cancer prevention organizations and CSOs 
Technical assistance to map existing relevant stakeholder platforms and communication networks (e.g., adolescent health, cancer prevention, civil society organizations, etc.) to leverage for continued communications/social mobilization on HPV vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.4: Support communications/social mobilization and community engagement activities">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">In May 2021, JSI co-facilitated a TWG meeting with key stakeholders to discuss the HPV routinization progress, including key challenges and successes, and with a focus on a way forward for the sustainability of the program, which includes strengthening collaboration and coordination with non-EPI partners with a vested interest in HPV. Participants included the EPI TWG members, integrated cervical cancer control partners, and the reproductive health unit adolescent health coordinator. As a result of this TWG meeting, JSI has collected the list of cancer screening partners and is in the process of mapping out their geographic presence to advocate for integration with the vaccination, especially in districts and health facilities that have not yet started vaccinating. These partners include: Partners in Hope, EGPAF, Lighthouse Trust, Baylor, Nkhoma Hospital, MALSCOT, MSF, DREAM, PST, and CHAI. JSI is also in discussion with the Health Promotion unit to engage celebrities through Adecots--a local NGO funded through USAID/HC4L that engages celebrities on reproductive health issues--to promote HPV vaccine through their Facebook pages and also the Moyo ndi Mpamba pages as well as the reproductive health unit to identify and map adolescent health partners. Moving forward, JSI will continue to work with the EPI to map existing partners and networks (e.g. cancer prevention, adolescent health, women?s associations) with whom to collaborate for sustainable messaging on cervical cancer control, which includes HPV vaccination, as a primary measure.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.4: Support communications/social mobilization and community engagement activities">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">In May 2021, JSI co-facilitated a TWG meeting with key stakeholders to discuss the HPV routinization progress, including key challenges and successes, and with a focus on a way forward for the sustainability of the program, which includes strengthening collaboration and coordination with non-EPI partners with a vested interest in HPV. Participants included the EPI TWG members, integrated cervical cancer control partners, and the reproductive health unit adolescent health coordinator. As a result of this TWG meeting, JSI has collected the list of cancer screening partners and is in the process of mapping out their geographic presence to advocate for integration with the vaccination, especially in districts and health facilities that have not yet started vaccinating. These partners include: Partners in Hope, EGPAF, Lighthouse Trust, Baylor, Nkhoma Hospital, MALSCOT, MSF, DREAM, PST, and CHAI. JSI is also in discussion with the Health Promotion unit to engage celebrities through Adecots--a local NGO funded through USAID/HC4L that engages celebrities on reproductive health issues--to promote HPV vaccine through their Facebook pages and also the Moyo ndi Mpamba pages as well as the reproductive health unit to identify and map adolescent health partners. Moving forward, JSI will continue to work with the EPI to map existing partners and networks (e.g. cancer prevention, adolescent health, women?s associations) with whom to collaborate for sustainable messaging on cervical cancer control, which includes HPV vaccination, as a primary measure.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to orient and build capacity of health workers and teachers to implement the new strategy to achieve high coverage for both doses, and improve processes with challenges during the second round</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.3: Support capacity building">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">In the absence of funding for in-person training, JSI supported the EPI to draft and send letters/guidance notes to the District Health Offices and Ministry of Education about the routinization of HPV in Jan. 2021. JSI also encouraged the use of virtual platforms to update the regional and district coordinators on HPV routinization. On Feb. 5, 2021, JSI co-facilitated a virtual meeting with district coordinators, zonal officers and partners (UNICEF, WHO) to discuss HPV routinization. Coordinators asked for clarification on HPV vaccine availability, communication activities, impact of COVID-19 misconceptions on HPV vaccine, and unpaid allowances to some district and facility officers and teachers. The EPI emphasized the content of the letter and guidance note shared in Jan. 2021, advising them to leverage all community engagement opportunities to inform the community on the change in delivery approach, to use the HPV registers in schools and health facilities to identify girls due for their second dose, and engage existing community structures to remind them to come to the health facility for vaccination. The meeting was attended by 30 participants, including 16/29 district coordinators.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided for partner coordination and collaboration in the implementation of HPV vaccination activities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.1: Partner coordination/engagement">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">JSI supported the EPI to develop the proposed HPV routinization strategy, including drafting the plan and facilitating regular consensus building meetings with partners (MoEST, College of Medicine, WHO and UNICEF). The proposed strategy was adopted at a stakeholders workshop in July 2020 (co-facilitated by JSI and the EPI). The date for routinization was updated from Oct. 2020 to Feb. 2021, due to COVID-19 related delays and postponement of vaccine shipment until Jan. 2021. 
In Jan. 2021, JSI supported the EPI to draft and send letters to the District Health Offices and Ministry of Education about the routinization of HPV. The letter communicated that starting in Feb. 2021, HPV vaccines would be administered in health facilities (HFs) year-round, with outreach to schools to take place during planned quarterly intervals when schools reopen. It included a guidance note that detailed key activities, roles, and responsibilities in the absence of formal briefings with health workers and teachers due to funding constraints as well as information on vaccine availability and the importance of community engagement to update girls and their parents on the new strategy. The guidance note also included information on how to use the HPV mapping and vaccination registers and ID cards in schools and at HFs to find girls due for their second dose. Letter contents were then shared with HFs. 
From March-May 2021, JSI conducted supportive supervision visits in 26 districts to monitor implementation of HPV routinization. Visit findings were shared with partners on an ongoing basis, and in May 2021, JSI co-facilitated an HPV-specific TWG meeting to review the findings and determine key activities to strengthen and maintain the program and to incorporate into the new cMYP. Cancer and adolescent health programs attended and supported a mapping of existing projects and platforms through which HPV could be integrated, including the revised cervical cancer elimination strategy (2022-2027).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical assistance provided to plan and implement improve processes with challenges during the second round</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Activity 1.2: Technical assistance to planning and implementation">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">JSI supported the drafting and finalization of a plan and timeline for HPV routinization, as well as development of a budget for key activities. With the continued delays (linked to COVID-19 and delay in shipment of HPV vaccines), the timeline was updated monthly. 
In support of HPV routinization, JSI recommended integrating HPV vaccine microplans into the routine EPI microplans. JSI supported the revision of microplanning tools to include data on the HPV vaccine and co-facilitated district briefings on the revised tools in Blantyre and Mzimba North districts and the development of microplans in Dowa and Ntchisi districts. 
Due to COVID-19-related interruptions and delivery delays of the second tranche of HPV vaccines, routinization was delayed from October 2020 to February 2021. This delay still allowed for girls due for their second dose of the HPV vaccine to receive it within the recommended interval of 15 months, accommodating even those who will need to delay for the next 3 months. JSI remained in daily communication with the EPI to ensure rapid distribution of the vaccines to the districts. Distribution began on February 9, 2021, with funding from WHO.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training of the managers, health promotion officers and vaccinators completed in 8 of districts ( including urban settings) districts.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support on ACSM institutional capacity building of health education services units at national and district levels">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Planning for this activity is in progress, the Health Education Services of the MOH and EPI program are finalizing the arrangements.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 districts district reports on ACSM activites documentation of lessons learnt completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to strengthen ACSM activities for immunisation services">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Reports with lessons learnt on immunisation activities documented for 9 districts (Mangochi, Mulanje, Neno, Kasungu, Mzimba, Karonga, Blantyre Urban, Lilongwe Urban and MzuzuUrban). Districts strengthened ACSM activities for immunisation services by inreased coverage through citizen forums, community radio and interpersonal communication in immunisation and other integrated areas for servide continuity. 
1,000 politicians, chiefs and religious leaders in 9 districts developed action plans to address issues (including immunisation bottlenecks, malaria and SRH) and over 70% of people with access to TVs (n= 1,140,989) are estimated to be reached through national television to promote immunisation in urban settings</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">REC microplans in 25 facilities in the two urban Districts developed place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate REC microplanning, implementation and monitoring in two Urban settings (Lilongwe &amp; Blantyre)">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Due to prioritization of COVID vaccination and delays to finalize the urban immunization strategy, this activity has been delayed. It is being re-planned to 4th quarter of 2021 by which time the urban immunization strategy will have been developed to ensure alignment of the microplanning process to the strategy</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate REC microplanning, implementation and monitoring in two Urban settings (Lilongwe &amp; Blantyre)">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Due to prioritization of COVID vaccination and delays to finalize the urban immunization strategy, this activity has been delayed. It is being re-planned to 4th quarter of 2021 by which time the urban immunization strategy will have been developed to ensure alignment of the microplanning process to the strategy</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate REC microplanning, implementation and monitoring in two Urban settings (Lilongwe &amp; Blantyre)">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Urban Immunization Strategy has been developed to inform the development of the REC microplans. Two urban settings (Lilongwe &amp; Blantyre) identified to demonstrate the development and use of the microplans. Plan is to develop the plans in these urban settings in January, 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on vaccine cold chain management including updated CCE inventory and functionality report are presented at EPI TWG meetings</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for skill transfer to EPI unit of the Ministry of Health and strengthen immunisation cold chain supply management including EVMA support, solarization of health facilities and monitoring of CCEOP project progress , including conducting Post Installation Inspection">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The Inventory Management Tool (IMT) was updated in March, 2021 to reflect quantities, functionality etc for all Cold Chain equipment at national, regional and district levels as part of the Gavi Cold Chain Equipment Application. UNICEF at country and regional level played a key role in supporting MOH to update the IMT which was presented and endorsed by the EPI sub TWG</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for skill transfer to EPI unit of the Ministry of Health and strengthen immunisation cold chain supply management including EVMA support, solarization of health facilities and monitoring of CCEOP project progress , including conducting Post Installation Inspection">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The Inventory Management Tool (IMT) was updated in March, 2021 to reflect quantities, functionality etc for all Cold Chain equipment at national, regional and district levels as part of the Gavi Cold Chain Equipment Application. UNICEF at country and regional level played a key role in supporting MOH to update the IMT which was presented and endorsed by the EPI sub TWG</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI 2021-22 draft budget  prepared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building to Malawi MOH on forecasting and budgetting for vaccine procurement and broader EPI program budgeting">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The consultancy has been awarded and is going to start its support by the end of June. The consultancy will last through November 2021 and provide MoH with a costing tool and the related SOPs, an assessment on the adequacy of the Supply Management Tool and opportunities to improve it and connected to existing systems as well as with the necessary material to request for an alignment of Government&apos;s CoA to better account for vaccines. In addition, as part of the preparation to conduct Effective Vaccine Management Assessment (EVMA), the UNICEF ESARO organized and conducted a capacity building training of EVM managers</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building to Malawi MOH on forecasting and budgetting for vaccine procurement and broader EPI program budgeting">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The consultancy has been awarded and is going to start its support by the end of June. The consultancy will last through November 2021 and provide MoH with a costing tool and the related SOPs, an assessment on the adequacy of the Supply Management Tool and opportunities to improve it and connected to existing systems as well as with the necessary material to request for an alignment of Government&apos;s CoA to better account for vaccines. In addition, as part of the preparation to conduct Effective Vaccine Management Assessment (EVMA), the UNICEF ESARO organized and conducted a capacity building training of EVM managers</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">District AEFI investigation teams training report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building on vaccine safety surveillance in the 9 Gavi target district">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">All districts have AEFI investigation teams that are trained. District trainings of health care workers on COVID-19 vaccine AEFI surveillance are underway</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI training plan in plan in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building on vaccine safety surveillance in the 9 Gavi target district">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Draft training plan is in place</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IPV catchup campaign microplans in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to implement IPV catchup campaign">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Microplans are under development. The IPV campaign has been scheduled for 12-17 July 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MR SIA microplans in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to implement MR SIA">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The MR SIA has been scheduled for October 2021 and the microplans will be developed in due course</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MR SIA technical report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to implement MR SIA">
      <location ref="MW"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The MR SIA was initially scheduled for October 2021. Current discussion is to consider integrating with TCV introduction in 2022. The tentative month for TCV introduction is October 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IPV SIA report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to implement IPV catchup campaign">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The nationwide catchup campaign was conducted from11 to 17 July 2021 and targeted 1,875,323 children who were missed during the switch from tOPV to bOPV in 2016 due to global supply of IPV vaccine. The post-campaign coverage survey was however not scheduled.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">District Health Management Teams in all the three pilot districts trained in MOV/2YL strategy and checklist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for implementation of MOV/2YL strategy in three pilot districts">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">This activity was implemented in November 2020</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of the targeted facilities in the three pilot districts with capacity to identify and vaccinate those who missed immunisations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for implementation of MOV/2YL strategy in three pilot districts">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Trainings of supervisors has been conducted. Training of health workers has however not commenced yet. Training tools and job aids are in place.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccine Wastage Study Report submitted to MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to conduct Vaccine Wastage Study for new vaccines (Rota, PCV,IPV) to provide evidence and basis for quantification and allocation of vaccines to districts and health facilities">
      <location ref="MW"></location>
     </target>
     <actual value="On Track">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">The process to recruit a consultant for this assignment is nearing completion and the consultant is expected to be on-board in the week beginning 21st June. The plan is to complete the assignment and have a final report by first week August, 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report shared with stakeholders.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance provided to implement, monitor and evaluate strategies to address causes of missed opportunities for vaccination and strengthen vaccination in the second year of life and beyond. There are several strategies outlined in the Malawi MOV plan, from which we will select a few to focus on implementing and evaluating in the three pilot districts, as previously discussed. This will be done in collaboration with the MoH and WHO Malawi MOV/2YL focal point, Zione Dembo.">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="MW"></location>
     </target>
     <actual value="Completed">
      <location ref="MW"></location>
      <comment>
       <narrative xml:lang="EN">Survaillance + EIR</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed
2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MW"></location>
     </target>
     <actual value="Major Delays">
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="MW"></location>
     </target>
     <actual>
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed 2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="MW"></location>
     </target>
     <actual>
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on VPD surveillance digital data package and know how to use it.
Costed scale up plan exist.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="MW"></location>
     </target>
     <actual>
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MW"></location>
     </target>
     <actual>
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MW"></location>
     </target>
     <actual>
      <location ref="MW"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
